For example, whereas inhibition of Kv11.1 function or expression reduces the proliferation of tumor cells in vitro and in vivo [19, 48–51], drugs developed to inhibit Kv11.1 cause cardiotoxicity [52]. This evidence concerns the gene KCNV2 and neoplasm.